부산대학교 도서관

AM Abukhdeir; MS Najor; SB Turturro; AR Armstrong; A McDonald; L Fogg; MA Cobleigh

Cancer Research. 78:P2-09

AM Abukhdeir; SB Turturro; MS Najor; SS Brar; MA Cobleigh

Cancer Research. 77:P6-11

Ma, C.X.; Thomas, S.; Anderson, J.; Haas, B.; Bose, R.; Luo, J.; Gao, F.; Freedman, R.A.; Lin, N.U.; Winer, E.P.; Pluard, T.J.; Nangia, J.R.; Lu, J.; Valdez-Albini, F.; Cobleigh, M.; Jones, J.M.; Kelly Marcom, P.; Kimmick, G.; Bucheit, L.; Bryce, R.; Lalani, A.S.; Carey, L.A.; Goetz, M.P.; Pegram, M.D.; Ellis, M.J.

In: Clinical Cancer Research. (Clinical Cancer Research, 1 April 2022, 28(7):1258-1267)

Cobleigh MA; Rush University Medical Center, 1620 W Harrison St, Chicago, IL, 60612, USA. melody_cobleigh@rush.edu.; Layng KV; Tempus Labs Inc, 600 W Chicago, Chicago, IL, 60654, USA.; Mauer E; Tempus Labs Inc, 600 W Chicago, Chicago, IL, 60654, USA.; Mahon B; Tempus Labs Inc, 600 W Chicago, Chicago, IL, 60654, USA.; Hockenberry AJ; Tempus Labs Inc, 600 W Chicago, Chicago, IL, 60654, USA.; Abukhdeir AM; Rush University Medical Center, 1620 W Harrison St, Chicago, IL, 60612, USA.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Oleske DM; Galvez A; Cobleigh MA; Ganschow P; Ayala LD

Breast Journal (BREAST J), Jan/Feb2007; 13(1): 19-27. (9p)

Oleske DM; Cobleigh MA; Phillips M; Nachman KL

Oncology Nursing Forum (ONCOL NURS FORUM), Nov2004; 31(6): 1081-1088. (8p)

O'Connell BC; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA brendaoconnell5@gmail.com.; Hubbard C; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.; Zizlsperger N; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.; Fitzgerald D; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.; Kutok JL; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.; Varner J; University of California San Diego, La Jolla, California, USA.; Ilaria R Jr; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.; Cobleigh MA; Rush University Medical Center, Chicago, Illinois, USA.; Juric D; Massachusetts General Hospital, Boston, Massachusetts, USA.; Tkaczuk KHR; University of Maryland School of Medicine, Baltimore, Maryland, USA.; Elias A; University of Colorado School of Medicine, Aurora, Colorado, USA.; Lee A; UT Health East Texas, Tyler, Texas, USA.; Dakhil S; Cancer Center of Kansas, Wichita, Kansas, USA.; Hamilton E; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Soliman H; Moffitt Cancer Center, Tampa, Florida, USA.; Peluso S; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Burstein HJ; Elias AD; Rugo HS; Cobleigh MA; Wolff AC; Eisenberg PD; Lehman M; Adams BJ; Bello CL; DePrimo SE; Baum CM; Miller KD; Burstein, Harold J; Elias, Anthony D; Rugo, Hope S; Cobleigh, Melody A; Wolff, Antonio C; Eisenberg, Peter D; Lehman, Mary; Adams, Bonne J

Journal of Clinical Oncology. 4/10/2008, Vol. 26 Issue 11, p1810-1816. 7p.

Ma, C.X.; Bose, R.; Naughton, M.; Thomas, S.; Anderson, J.; Bumb, C.; Gao, F.; Freedman, R.A.; Winer, E.; Telli, M.L.; Kimmick, G.; Blackwell, K.; Goetz, M.P.; Russell, C.; Tripathy, D.; Cobleigh, M.; Forero, A.; Pluard, T.J.; Anders, C.; Niravath, P.A.; Ellis, M.J.C.; Banks, K.C.; Lanman, R.B.; Bryce, R.; Lalani, A.S.; Pfeifer, J.; Al-Kateb, H.; Hayes, D.F.; Pegram, M.; Bedard, P.L.

In: Clinical Cancer Research. (Clinical Cancer Research, 1 October 2017, 23(19):5687-5695)

Tangney, CC; Young, JA; Murtaugh, MA; Cobleigh, MA; Oleske, DM

BREAST CANCER RESEARCH AND TREATMENT; JAN 2002, 71 2, p113-p123, 11p.

DiScala M; Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.; Najor MS; Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.; Yung T; Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.; Morgan D; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Missouri, United States of America.; Abukhdeir AM; Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.; Cobleigh MA; Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Cobleigh, MA; Tabesh, B; Bitterman, P; Baker, J; Cronin, M; Liu, ML; Borchik, R; Mosquera, JM; Walker, MG; Shak, S

CLINICAL CANCER RESEARCH; DEC 15 2005, 11 24, p8623-p8631, 9p.

Miller, KD; Chap, LI; Holmes, FA; Cobleigh, MA; Marcom, PK; Fehrenbacher, L; Dickler, M; Overmoyer, BA; Reimann, JD; Sing, AP; Langmuir, V; Rugo, HS

JOURNAL OF CLINICAL ONCOLOGY; FEB 1 2005, 23 4, p792-p799, 8p.

Winer, EP; Hudis, C; Burstein, HJ; Wolff, AC; Pritchard, KI; Ingle, JN; Chlebowski, RT; Gelber, R; Edge, SB; Gralow, J; Cobleigh, MA; Mamounas, EP; Goldstein, LJ; Whelan, TJ; Powles, TJ; Bryant, J; Perkins, C; Perotti, J; Braun, S; Langer, AS; Browman, GP; Somerfield, MR

JOURNAL OF CLINICAL ONCOLOGY; JAN 20 2005, 23 3, p619-p629, 11p.

Miller, KD; Saphner, TJ; Waterhouse, DM; Chen, TT; Rush-Taylor, A; Sparano, JA; Wolff, AC; Cobleigh, MA; Galbraith, S; Sledge, GW

CLINICAL CANCER RESEARCH; MAR 15 2004, 10 6, p1971-p1975, 5p.

Cobleigh, MA; Langmuir, VK; Sledge, GW; Miller, KD; Haney, L; Novotny, WF; Reimann, JD; Vassel, A

SEMINARS IN ONCOLOGY; OCT 2003, 30 5, p117-p124, 8p. Supplement: 16

Vogel, CL; Cobleigh, MA; Tripathy, D; Gutheil, JC; Harris, LN; Fehrenbacher, L; Slamon, DJ; Murphy, M; Novotny, WF; Burchmore, M; Shak, S; Stewart, SJ; Press, M

JOURNAL OF CLINICAL ONCOLOGY; FEB 1 2002, 20 3, p719-p726, 8p.

Vogel, C; Cobleigh, MA; Tripathy, D; Gutheil, JC; Harris, LN; Fehrenbacher, L; Slamon, DJ; Murphy, M; Novotny, WF; Burchmore, M; Shak, S; Stewart, SJ; Genentech H0650 Study Investigators

EUROPEAN JOURNAL OF CANCER; JAN 2001, 37 pS25-pS29, 5p. Supplement: 1

Vogel CL; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Cobleigh MA; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Tripathy D; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Gutheil JC; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Harris LN; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Fehrenbacher L; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Slamon DJ; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Murphy M; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Novotny WF; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Burchmore M; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Shak S; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Stewart SJ; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.; Press M; From University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, and Columbia Cancer Research Network of Florida, Miami, FL; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; University of California, San Francisco/Mount Zion Cancer Center, San Francisco; Sidney Kimmel Cancer Center, San Diego; Kaiser Permanente, Vallejo; University of California Los Angeles School of Medicine and University of Southern California School of Medicine, Los Angeles; Genentech, Inc, South San Francisco, CA; and Duke University Medical Center, Durham, NC.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE

Cobleigh MA; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Vogel CL; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Tripathy D; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Robert NJ; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Scholl S; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Fehrenbacher L; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Wolter JM; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Paton V; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Shak S; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Lieberman G; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.; Slamon DJ; From the Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; Columbia (HCA) Cancer Research Network of Florida, Aventura, FL; University of California, San Francisco Cancer Center, San Francisco, Kaiser Permanente, Northern California, Vallejo, Genentech, Inc, South San Francisco, and UCLA School of Medicine, Los Angeles, CA; Fairfax Prince William Hospital, Annandale, VA; and Institut Curie, Paris, France.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE